Also published in GlobeNewswire:
Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire
x hide permanently

VYNE Therapeutics Announces the Appointment of Patrick G. LePore to its Board of Directors


VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that the Board of Directors of the Company appointed Mr. Patrick G. LePore to serve as a director of the Company, effective as of September 10, 2020...

Mentions: Nasdaq Board Board of directors